A Capacitance and Transepidermal Water Loss Test to Determine the Ability of Sunscreen to Moisturize Skin

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00368563

Enrollment

Unknown

Registered

2006-08-24

Start date

2006-08-31

Completion date

2006-10-31

Last updated

2009-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Skin

Brief summary

To evaluate the ability of 2 Helioblock SX Cream formulations to moisturize skin using capacitance and transepidermal water loss methodology

Interventions

DRUGHelioblock SX

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Inclusion criteria

* Healthy,male or female subjects 18 years to 55 years of age, with a minimum Stanfield score at baseline of 2 at the forearm sites intended to be assessed in the study * Female subjects of childbearing potential using a reliable form of contraception during the course of the study(oral contraceptive pill, intrauterine device, bilateral tubal ligation, abstinence, or other reliable forms at the discretion of the Investigator.) or of non childbearing potential(i.e.,post-menopausal(one year without menstrual period), hysterectomy or bilateral ovariectomy) * Subjects who have read, understood and signed an informed consent * Subjects who are willing and capable of cooperating to the extent and degree required by the protocol * Absence of any visible skin diseases which might be confused with a skin reaction from the test material

Exclusion criteria

* Subjects with a condition, or in a situation, which in the Investigator's or Sub-Investigator's opinion, may suggest a significant hazard for the subject, may confound the study results, or may interfere with the subject's participation in the study. * Subjects with known sensitivities to any of the study preparations or to other skin care products * Subjects who have participated in a clinical research study, including consumer products studies, within the last 30 days prior to enrollment * Subjects who are currently receiving medication(prescription or OTC) that in the opinion of the Investigator may interfere with the evaluations made in this study (e.g.vasoactive substances) * Pregnant or nursing females or women who are planning to get pregnant during the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026